EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report) has been given an average rating of “Buy” by the eight research firms that are currently covering the firm, Marketbeat Ratings reports. Eight investment analysts have rated the stock with a buy rating. The average 1 year price target among analysts that have issued ratings on the […]

Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) have been given a consensus rating of “Moderate Buy” by the twenty-two brokerages that are presently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, four have given a hold rating, sixteen have given a buy rating and […]

American International Group, Inc. (NYSE:AIG – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the fifteen analysts that are presently covering the stock, MarketBeat reports. Seven investment analysts have rated the stock with a hold rating and eight have issued a buy rating on the company. The average 12 month […]

Shares of ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Get Free Report) have earned an average recommendation of “Buy” from the seven research firms that are currently covering the firm, MarketBeat reports. Seven equities research analysts have rated the stock with a buy recommendation. The average 12-month target price among brokers that have updated their coverage on […]